Search results
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 6 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 1 day agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 6 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Stock Market Today: Dow rides broadening out of rally to notch 4th weekly win By Investing.com
Investing.com· 7 days agoInvesting.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out...
Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall By Investing.com
Investing.com· 6 days agoMidday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 3 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
Benjamin F. Edwards & Company Inc. Raises Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 5 days agoBenjamin F. Edwards & Company Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 17.2% during the 4th quarter, according to its most...Securities ...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 1 day agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy. Novavax Stock Just...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...